Vertex (VRTX) Shares Halted with News Pending Following Confirmation of FDA Approval of KALYDECO
Tweet
Share
E-mailGet Alerts VRTX Hot Sheet
Join SI Premium – FREE
Shares of Vertex (Nasdaq: VRTX) halted with news pending following the company's release for the FDA approval of KALYDECO.
Stock currently up 8.8%.
Stock currently up 8.8%.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Vortex Energy Announces Final Ambient Noise Tomography Results for the Robinsons River Salt Project
- FDA grants Nuvation Bio fast track status for brain cancer drug
- Ionis to present olezarsen and ION775 data at ESC Congress 2026
Create E-mail Alert Related Categories
FDA, Trading HaltsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
